Beam Therapeutics (NASDAQ:BEAM) shared promising results from the early stage trial of its genetically modified cell therapy, ...

Recent cuts to the CDC are affecting women suffering from chronic diseases. In April, the group that was responsible for evaluating research and recommending birth control methods for patients with ...

SOKENDAI and Kyushu University have uncovered the molecular mechanism that drives the "ticking" of the circadian clock in ...

Memorial Sloan Kettering Cancer Center researchers have identified a metabolic switch that determines whether intestinal stem ...

Ever wondered how scientists peek inside our cells, analyzing their secrets to diagnose diseases or develop life-saving ...

Poster Title: ARV-393, a PROteolysis TArgeting Chimera (PROTAC) BCL6 Degrader, is Efficacious in Preclinical Models of ...

Genetic research, single-cell RNA sequencing, and spatial transcriptomics suggest that a prolonged anagen stage in the ...